BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23442544)

  • 21. SPECT/CT in patients with lower back pain after lumbar fusion surgery.
    Sumer J; Schmidt D; Ritt P; Lell M; Forst R; Kuwert T; Richter R
    Nucl Med Commun; 2013 Oct; 34(10):964-70. PubMed ID: 23820764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High predictive value of F-18 FDG PET patterns of the spine for metastases or benign lesions with good agreement between readers.
    Bohdiewicz PJ; Wong CY; Kondas D; Gaskill M; Dworkin HJ
    Clin Nucl Med; 2003 Dec; 28(12):966-70. PubMed ID: 14663317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skeletal SPECT/CT of the peripheral extremities.
    Linke R; Kuwert T; Uder M; Forst R; Wuest W
    AJR Am J Roentgenol; 2010 Apr; 194(4):W329-35. PubMed ID: 20308478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone scintigraphy in breast cancer: added value of hybrid SPECT-CT and its impact on patient management.
    Sharma P; Singh H; Kumar R; Bal C; Thulkar S; Seenu V; Malhotra A
    Nucl Med Commun; 2012 Feb; 33(2):139-47. PubMed ID: 22157698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [SPECT/CT fusion imaging for the diagnosis of benign and malignant lesions in bones].
    Zhao Z; Li FL; Zhao LX; Su MG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):1036-9. PubMed ID: 19253855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of fused SPECT/CT in the evaluation of solitary skull lesion.
    Gayed IW; Kim EE; Awad J; Joseph U; Wan D; John S
    Clin Nucl Med; 2011 Jul; 36(7):538-41. PubMed ID: 21637054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The benefit of SPECT when added to planar scintigraphy in patients with bone metastases in the spine.
    Sedonja I; Budihna NV
    Clin Nucl Med; 1999 Jun; 24(6):407-13. PubMed ID: 10361935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tomographic imaging in the diagnosis of pulmonary embolism: a comparison between V/Q lung scintigraphy in SPECT technique and multislice spiral CT.
    Reinartz P; Wildberger JE; Schaefer W; Nowak B; Mahnken AH; Buell U
    J Nucl Med; 2004 Sep; 45(9):1501-8. PubMed ID: 15347717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients.
    Guezennec C; Keromnes N; Robin P; Abgral R; Bourhis D; Querellou S; de Laroche R; Le Duc-Pennec A; Salaün PY; Le Roux PY
    Cancer Imaging; 2017 Jun; 17(1):16. PubMed ID: 28592305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation.
    Schmidt D; Szikszai A; Linke R; Bautz W; Kuwert T
    J Nucl Med; 2009 Jan; 50(1):18-23. PubMed ID: 19091884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Added value of SPECT/CT in patients suspected of having bone infection: preliminary results.
    Horger M; Eschmann SM; Pfannenberg C; Storek D; Vonthein R; Claussen CD; Bares R
    Arch Orthop Trauma Surg; 2007 Apr; 127(3):211-21. PubMed ID: 17146681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of SPECT/CT in skeletal malignancies.
    Ghosh P
    Semin Musculoskelet Radiol; 2014 Apr; 18(2):175-93. PubMed ID: 24715449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
    Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R
    J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two-phase (201)Tl SPECT with chest CT to differentiate thoracic malignancies from benign lesions.
    Yu YH; Hsu WH; Hsu NY; Chang YC; Tsai PP; Tseng GC; Sun SS; Chiui YF
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):66-73. PubMed ID: 18235422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of focal bone lesions in the axial skeleton: performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT.
    Strobel K; Burger C; Seifert B; Husarik DB; Soyka JD; Hany TF
    AJR Am J Roentgenol; 2007 May; 188(5):W467-74. PubMed ID: 17449746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should SPECT-CT replace SPECT for the evaluation of equivocal bone scan lesions in patients with underlying malignancies?
    Ndlovu X; George R; Ellmann A; Warwick J
    Nucl Med Commun; 2010 Jul; 31(7):659-65. PubMed ID: 20395878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indeterminate lesions on planar bone scintigraphy in lung cancer patients: SPECT, CT or SPECT-CT?
    Sharma P; Kumar R; Singh H; Bal C; Julka PK; Thulkar S; Malhotra A
    Skeletal Radiol; 2012 Jul; 41(7):843-50. PubMed ID: 22002100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can hybrid SPECT-CT overcome the limitations associated with poor imaging properties of 131I-MIBG?: Comparison with planar scintigraphy and SPECT in pheochromocytoma.
    Sharma P; Dhull VS; Jeph S; Reddy RM; Singh H; Naswa N; Bal C; Kumar R
    Clin Nucl Med; 2013 Sep; 38(9):e346-53. PubMed ID: 23510889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients.
    Römer W; Nömayr A; Uder M; Bautz W; Kuwert T
    J Nucl Med; 2006 Jul; 47(7):1102-6. PubMed ID: 16818944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.